Literature DB >> 1385553

The interferons, macrophage activation, and host defense against nonviral pathogens.

H W Murray1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1385553     DOI： 10.1089/jir.1992.12.319

Source DB:  PubMed          Journal:  J Interferon Res        ISSN： 0197-8357


× No keyword cloud information.
  8 in total

Review 1.  IFNs and STATs in innate immunity to microorganisms.

Authors:  Thomas Decker; Silvia Stockinger; Marina Karaghiosoff; Mathias Müller; Pavel Kovarik
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Molecular and functional characterization of turkey interferon.

Authors:  M Suresh; K Karaca; D Foster; J M Sharma
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

3.  Production of interferons in human placental trophoblast subpopulations and their possible roles in pregnancy.

Authors:  G Aboagye-Mathiesen; F D Tóth; M Zdravkovic; P Ebbesen
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

4.  Antiparasitic and antiproliferative effects of indoleamine 2,3-dioxygenase enzyme expression in human fibroblasts.

Authors:  S L Gupta; J M Carlin; P Pyati; W Dai; E R Pfefferkorn; M J Murphy
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

5.  In vitro activation of a transcription factor by gamma interferon requires a membrane-associated tyrosine kinase and is mimicked by vanadate.

Authors:  K Igarashi; M David; A C Larner; D S Finbloom
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures.

Authors:  Bingyun Li; Bingbing Jiang; Matthew J Dietz; E Suzanne Smith; Nina B Clovis; K Murali Krishna Rao
Journal:  J Orthop Res       Date:  2010-01       Impact factor: 3.494

7.  IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.

Authors:  Elizabeth K Naglak; Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2016-09-06       Impact factor: 3.441

8.  Cells infected with Yersinia present an epitope to class I MHC-restricted CTL.

Authors:  M N Starnbach; M J Bevan
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.